期刊文献+

氧化高密度脂蛋白及其亚型对人脐静脉内皮细胞组织因子途径抑制物-1表达的影响 被引量:1

OxHDL and its subfractions on tissue factor pathway inhibitor-1 expression in human umbilical vein endothelial cells
暂未订购
导出
摘要 目的探讨氧化高密度脂蛋白(oxHDL)及其亚型对人脐静脉内皮细胞(HUVECs)组织因子途径抑制物-1(TFPI-1)表达的影响。方法以天然HDL及其亚型作为对照,HUVECs分别经不同浓度(0,10,20,40,80 mg/L)oxHDL、oxHDL2、oxHDL3孵育24 h,逆转录聚合酶链反应(RT-PCR)、Western印迹分别检测TFPI-1 mRNA及蛋白质表达。结果与对照组比较,oxHDL、oxHDL2、oxHDL3能抑制TFPI-1 mRNA和蛋白表达,其中在oxHDL和oxHDL3各系列浓度中以40 mg/L作用最明显,TFPI-1 mRNA和蛋白表达分别下降了28%、35%和49%、47%;在oxHDL2各系列浓度中以80 mg/L作用最明显,TFPI-1 mRNA和蛋白表达均下降了27%,差异均具有统计学意义(P<0.05);且以oxHDL3的作用最强。结论 oxHDL及其亚型能抑制HUVECs TFPI-1 mRNA和蛋白表达,oxHDL3的作用最强。 Objective To investigate the expression of tissue factor pathway inhibitor-1 (TFPI-1) induced by oxidized high densi- five lipopmtein (HDL) and its subfractions in human umbilical vein endothelial cells (HUVECs). Methods HUVECs were incubated with oxHDL, oxHDL2, oxHDL3 or their native forms at different concentrations (0,10,20,40,80 mg/L)for 24 h. TFPI-1 mRNA and" protein ex- pressions were determined by RT-PCR and Western blot, respectively. Results Compared with control group(ie. HDL, HDL2 or HDL3), oxHDL, oxHDL2, oxHDL3 significantly decreased the expressions of TFPI-1 mRNA and protein, respectively. TFPI-1 mRNA and protein ex- pressions were lowered by oxHDL by 28% and 35% , respectively at the level of 40 rag/L, by oxHDL2 by 27% and 27% at the level of 80 rag/L, and by oxHDL3 by 49% and 47%, respectively, at the level of 40 mg/L ( all P 〈 0. 05 ). The effect of oxHDL3 appeared the strongest. Conclusions Ox-HDL and its subfractions could inhibit the expression levels of TFPI-1 mRNA and nrotein in HUVECs.
出处 《中国老年学杂志》 CAS CSCD 北大核心 2012年第21期4660-4662,共3页 Chinese Journal of Gerontology
基金 国家自然科学基金资助(30971169) 湖南省大学生研究性学习和创新性实验课题(湘教通〔2008〕91号) 湖南省高校科技创新团队资助计划(2008-244) 南华大学留学归国人员科研启动基金资助
关键词 高密度脂蛋白 氧化修饰 组织因子途径抑制物 1 动脉粥样硬化 High-density lipoprotein Subfractions Oxidative modification tissue factor pathway inhibitor(TFPI)-1 Atherosclerosis
  • 相关文献

参考文献15

  • 1Pedersen B,Holscher T,SatoY,et al.A balance between tissue factor and tissue factor pathway inhibitor is required for embryonic development and hemostasis in adult mice(J).Blood,2005;105(7):2777-882.
  • 2Young CE,Karas RH,Kuvin JT.High-density lipoprotein cholesterol and coronary heart disease(J).Cardiol Rev,2004;12(2):107-19.
  • 3Lund-Katz S,Liu L,Thuahnai ST,et al.High density lipoprotein structure(J).Front Biosci,2003;8(1):d1044-54.
  • 4Asztalos BF,Schaefer EJ.High-density lipoprotein subpopulations in path-ologic conditions(J).Am J Cardiol,2003;91(7A):12E-17E.
  • 5Thorne RF,Mhaidat NM,Ralston KJ,et al.CD36 is a receptor for oxidized high density lipoprotein:Implications for the development of atherosclero-sis(J).FFBS Lett,2007;581(6):1227-32.
  • 6赵战芝 姜志胜 卜梓斌等.ox-LDL3、ox-LDL诱导THP-1单核源性巨噬细胞表达IL-1β、IL-6、HLA-DR、CD86.中国免疫学杂志,2008,24(4):365-370,373.
  • 7刘录山,危当恒,杨永宗.高密度脂蛋白和氧化型高密度脂蛋白对ECV-304分泌一氧化氮、一氧化氮合酶和内皮素1的影响[J].中国动脉硬化杂志,2002,10(5):421-423. 被引量:10
  • 8邓祖跃,刘秉文,周静,张祖辉,刘宇,白怀.脂蛋白的氧化修饰对血凝及纤溶活性的影响[J].中国病理生理杂志,2004,20(10):1773-1777. 被引量:5
  • 9Giuseppe N,Cristina B.Oxidised-HDL3 induces the expression of PAI-1 in human endothelial cells:role of p38MAPK activation and mRNA stabi-lization(J).Br J Haematol,2004;127(1):97-104.
  • 10Dahm A,Van Hylckama Vlieg A,Bendz B,et al.Low levels of tissue fac-tor pathway inhibitor(TFPI)increase the risk of venous thrombosis(J).Blood,2003;101(11):4387-92.

二级参考文献38

  • 1张林华,刘秉文.一次性密度梯度超速离心分离人血清脂蛋白[J].生物化学与生物物理学报,1989,21(3):257-260. 被引量:116
  • 2刘伟,朱自强,祖淑玉,朱广瑾.肾上腺髓质素对oxLDL诱导的HUVECs组织因子及其抑制物表达的干预作用[J].中国病理生理杂志,2006,22(1):12-16. 被引量:1
  • 3汪浩川,刘秉文,付明德.氧化修饰脂蛋白刺激人动脉平滑肌细胞DNA合成[J].生物化学与生物物理进展,1996,23(6):544-547. 被引量:17
  • 4洪梅,宋毅峰,李军,胡豫,宋善俊.ApoE-/-小鼠动脉粥样硬化病变中稳定斑块组织因子的表达[J].临床心血管病杂志,2007,23(5):357-360. 被引量:3
  • 5Steffel J,Akhmedov A,Greutert H,et al.Histamine induces tissue factor expression implications for acute coronary syndromes[J].Circulation,2005,112(3):341-349.
  • 6Kenneth J,Livak,Thomas D,et al.Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCt method[J].Methods,2001,25(4):402-408.
  • 7Moons AH,Levi M,Peters RJ.Tissue factor and coronary artery disease[J].Cardiovasc Res,2002,53(2):313-325.
  • 8Felmeden DC,Spencer CG,Chung NA,et al.Relation of thrombogenesis in systemic hypertension to angiogenesis and endothelial damage/dysfunction:a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial[J].Am J Cardiol,2003,92(4):400-405.
  • 9Blann AD,Amiral J,McCollum CN,et al.Differences in free and total tissue factor pathway inhibitor,and tissue factor in peripheral artery disease compared to healthy controls[J].Atherosclerosis,2000,152(1):29-34.
  • 10Lim HS,Blann AD,Lip GY.Soluble CD40 ligand,soluble P-selectin,interleukin-6,and tissue factor in diabetes mellitus:relationships to cardiovascular disease and risk factor intervention[J].Circulation,2004,109(21):2524-2528.

共引文献20

同被引文献2

引证文献1

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部